Gene therapy for hemophilia B, a rare bleeding disorder, reinforces lower bleeding rates and improved outcomes.

Russell Ryan, MD, and his team’s discovery appears to address longstanding mysteries about mutations found in B-cell acute lymphoblastic leukemia

The American Association for the Advancement of Science elected 17 University of Michigan faculty and staff members as 2022 Fellows.

For some patients, immunotherapy furthers tumor progression instead of halting it. What distinguishes those who benefit from those who don’t?

Michigan Medicine experts share how their work is contributing to gender-affirming and other forms of equitable health care for the LGBTQ+ community.